FDA adds heart attack and stroke warning to some painkillers

The U.S. Food and Drug Administration (FDA) is calling on drug makers of some popular painkillers to strengthen their warning labels after a review of new safety information. The warning labels on non-aspirin nonsteroidal anti-inflammatory drugs, known as NSAIDs, must be udpated to identify an increased risk of a heart attack or stroke.